Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2019/esmo-2019-prostate-cancer/115380-esmo-2019-profound-phase-3-study-of-olaparib-versus-enzalutamide-or-abiraterone-for-mcrpc-with-homologous-recombination-repair-gene-alterations.html?utm_source=newsletter_7026&utm_medium=email&utm_campaign=draft-for-approval-biomarker-selected-targeted-therapeutic-options-for-prostate-cancer-esmo-2019
If you do not want to visit that page, you can close this browser tab.
